Nonmalignant diseases and treatments associated with primary ovarian failure: An expanded role for fertility preservation

Journal of Women's Health

Volumn 20, Issue 10, 2011, Pages 1467-1477

  Hirshfeld Cytron, Jennifer ^a,b   Gracia, Clarisa ^c   Woodruff, Teresa K ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANAGRELIDE; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; GONADORELIN AGONIST; HYDROXYCHLOROQUINE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL CONTRACEPTIVE AGENT; SALAZOSULFAPYRIDINE;

AMENORRHEA; ARTICLE; AWARENESS; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; ENTERITIS; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GALACTOSEMIA; HEALTH CARE PERSONNEL; HEMOCHROMATOSIS; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MULTIPLE SCLEROSIS; OVARY INSUFFICIENCY; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TURNER SYNDROME;

ADULT; FEMALE; FERTILITY PRESERVATION; GASTROINTESTINAL DISEASES; GENITAL DISEASES, FEMALE; HUMANS; KIDNEY DISEASES; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES; PRIMARY OVARIAN INSUFFICIENCY; RHEUMATIC DISEASES; THERAPEUTICS;

EID: 80053987592     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2625     Document Type: Article

References (119)

1. Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 2007;39:447-451. (Pubitemid 46605202)
2. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911-921.
3. Kodaman PH. Early menopause: Primary ovarian insufficiency and surgical menopause. Semin Reprod Med 2010; 28:360-369.
4. Griesshammer M, Bergmann L, Pearson T. Fertility, pregnancy and the management of myeloproliferative disorders. Baillieres Clin Haematol 1998;11:859-874. (Pubitemid 29452767)
5. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 1999;33:65-76. (Pubitemid 29116395)
6. Mok CC, Lau CS, Wong RW. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 1998;41: 831-837. (Pubitemid 28225783)
7. Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxf ) 2007;46:1634-1640. (Pubitemid 350018482)
8. Tarnacka B, Rodo M, Cichy S, Czlonkowska A. Procreation ability in Wilson's disease. Acta Neurol Scand 2000;101: 395-398.
9. Martin F, Lauwerys B, Lefebvre C, Devogelaer JP, Houssiau FA. Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 1997;6:254-257. (Pubitemid 27160644)
10. Huong DL, Amoura Z, Duhaut P, et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002;29:2571-2576. (Pubitemid 35416964)
11. Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 2001;34:1561-1568. (Pubitemid 34874039)
12. Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993;119:366-369. (Pubitemid 23310085)
13. Wetzels JF. Cyclophosphamide-induced gonadal toxicity: A treatment dilemma in patients with lupus nephritis? Neth J Med 2004;62:347-352. (Pubitemid 39549517)
14. Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 2004;13:569-574. (Pubitemid 39145485)
15. Katsifis GE, Tzioufas AG. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 2004;13:673-678. (Pubitemid 39279782)
16. Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010;69:61-64.
17. Ioannidis JP, Katsifis GE, Tzioufas AG, Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 2002;29:2129-2135.
18. Boumpas DT, Sidiropoulos P, Bertsias G. Optimum therapeutic approaches for lupus nephritis: What therapy and for whom? Nat Clin Pract Rheumatol 2005;1:22-30.
19. Fine DM. Pharmacological therapy of lupus nephritis. JAMA 2005;293:3053-3060. (Pubitemid 40965076)
20. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35:112-121. (Pubitemid 41356587)
21. Gourley MF, Austin HA 3rd, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 1996;125:549-557. (Pubitemid 126450087)
22. Appenzeller S, Blatyta PF, Costallat LT. Ovarian failure in SLE patients using pulse cyclophosphamide: Comparison of different regimes. Rheumatol Int 2008;28:567-571. (Pubitemid 351422620)
23. Singh G, Saxena N, Aggarwal A, Misra R. Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus. J Rheumatol 2007;34:731-733. (Pubitemid 46641378)
24. Takada K, Arefayene M, Desta Z, et al. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum 2004;50:2202-2210. (Pubitemid 38924398)
25. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000;160:610-619. (Pubitemid 30140410)
26. Silva CA, Brunner HI. Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 2007;16:593-599. (Pubitemid 47359994)
27. Riley P, Maillard SM, Wedderburn LR, Woo P, Murray KJ, Pilkington CA. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology (Oxf ) 2004;43:491-496. (Pubitemid 38495769)
28. Brunner HI, Bishnoi A, Barron AC, et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 2006;15:198-206.
29. Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis ( JIA). Clin Exp Rheumatol 2003;21:347-350. (Pubitemid 36747831)
30. Ghezzi A, Zaffaroni M. Female-specific issues in multiple sclerosis. Expert Rev Neurother 2008;8:969-977. (Pubitemid 351872600)
31. Cocco E, Sardu C, Gallo P, et al. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: The FEMIMS study. Mult Scler 2008;14:1225-1233.
32. Cigni A, Faedda R, Atzeni MM, et al. Hormonal strategies for fertility preservation in patients receiving cyclophosphamide to treat glomerulonephritis: A nonrandomized trial and review of the literature. Am J Kidney Dis 2008;52: 887-896.
33. Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008;3:392-396.
34. Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007;14:119-125. (Pubitemid 46467522)
35. Levy DP, Giatras I, Jungers P. Pregnancy and end-stage renal disease-Past experience and new insights. Nephrol Dial Transplant 1998;13:3005-3007. (Pubitemid 28534695)
36. Guazzelli CA, Torloni MR, Sanches TF, Barbieri M, Pestana JO. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation 2008;86:669-672.
37. Kettas E, Cayan F, Akbay E, Kiykim A, Cayan S. Sexual dysfunction and associated risk factors in women with endstage renal disease. J Sex Med 2008;5:872-877. (Pubitemid 351472197)
38. Leavey SF, Weitzel WF. Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 2002;31: 107-119. (Pubitemid 34578616)
39. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-1429. (Pubitemid 350181588)
40. Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005;140:300-310. (Pubitemid 41001826)
41. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-1451.
42. Gorgun E, Remzi FH, Goldberg JM, et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery 2004;136:795-803. (Pubitemid 39311305)
43. Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004;47:1119-1126. (Pubitemid 38857058)
44. Stein SL, Michelassi F. How can fecundity be preserved in patients undergoing pelvic surgery? Nat Clin Pract Gastroenterol Hepatol 2008;5:308-309. (Pubitemid 351803601)
45. Oresland T, Palmblad S, Ellstrom M, Berndtsson I, Crona N, Hulten L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 1994;9:77-81. (Pubitemid 24157626)
46. Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: Female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002;122:15-19. (Pubitemid 34049189)
47. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: A meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006;55:1575-1580. (Pubitemid 44629206)
48. Mortier PE, Gambiez L, Karoui M, et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol 2006;30:594-597. (Pubitemid 43844284)
49. Alborzi S, Momtahan M, Parsanezhad ME, Dehbashi S, Zolghadri J. A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 2004;82:1633-1637. (Pubitemid 39611393)
50. Beretta P, Franchi M, Ghezzi F, Busacca M, Zupi E, Bolis P. Randomized clinical trial of two laparoscopic treatments of endometriomas: Cystectomy versus drainage and coagulation. Fertil Steril 1998;70:1176-1180. (Pubitemid 28546252)
51. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Crosignani PG. Surgery for endometriosis-associated infertility: A pragmatic approach. Hum Reprod 2009;24:254-269.
52. Busacca M, Vignali M. Endometrioma excision and ovarian reserve: A dangerous relation. J Minim Invasive Gynecol 2009;16:142-148.
53. Catenacci M, Sastry S, Falcone T. Laparoscopic surgery for endometriosis. Clin Obstet Gynecol 2009;52:351-361.
54. Xu M, Kreeger PK, Shea LD, Woodruff TK. Tissueengineered follicles produce live, fertile offspring. Tissue Eng 2006;12:2739-2746. (Pubitemid 46141242)
55. Benaglia L, Somigliana E, Vercellini P, Abbiati A, Ragni G, Fedele L. Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation. Hum Reprod 2009;24:2183-2186.
56. Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006;46:630-636.
57. Gidoni Y, Holzer H, Tulandi T, Tan SL. Fertility preservation in patients with nononcological conditions. Reprod Biomed Online 2008;16:792-800. (Pubitemid 351865341)
58. Somali M, Mpatakoias V, Avramides A, et al. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases. Gynecol Endocrinol 2005;21:18-26. (Pubitemid 41097791)
59. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-266.
60. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-2931. (Pubitemid 46655598)
61. Ghazizadeh S, Lessan-Pezeshki M, Khatami MR, et al. Infertility among kidney transplant recipients. Saudi J Kidney Dis Transpl 2007;18:79-82.
62. Fuchs KM, Wu D, Ebcioglu Z. Pregnancy in renal transplant recipients. Semin Perinatol 2007;31:339-347. (Pubitemid 350191956)
63. Christopher V, Al-Chalabi T, Richardson PD, et al. Pregnancy outcome after liver transplantation: A single-center experience of 71 pregnancies in 45 recipients. Liver Transplant 2006;12:1138-1143. (Pubitemid 44063790)
64. Douglas NC, Shah M, Sauer MV. Fertility and reproductive disorders in female solid organ transplant recipients. Semin Perinatol 2007;31:332-338. (Pubitemid 350191955)
65. Tuck SM. Fertility and pregnancy in thalassemia major. Ann NY Acad Sci 2005;1054:300-307. (Pubitemid 43031037)
66. Bradley RJ, Rosen MP. Subfertility and gastrointestinal disease: ''Unexplained'' is often undiagnosed. Obstet Gynecol Surv 2004;59:108-117. (Pubitemid 38140842)
67. Reubinoff BE, Har-El R, Kitrossky N, et al. Increased levels of redox-active iron in follicular fluid: A possible cause of free radical-mediated infertility in beta-thalassemia major. Am J Obstet Gynecol 1996;174:914-918. (Pubitemid 26111670)
68. Farina G, Pedrotti C, Cerani P, et al. Successful pregnancy following gonadotropin therapy in a young female with juvenile idiopathic hemochromatosis and secondary hypogonadotropic hypogonadism. Haematologica 1995;80: 335-337.
69. Meyer WR, Hutchinson-Williams KA, Jones EE, DeCherney AH. Secondary hypogonadism in hemochromatosis. Fertil Steril 1990;54:740-742. (Pubitemid 20350672)
70. Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: Reversal with iron depletion. Ann Intern Med 1984;101:629-632. (Pubitemid 15223301)
71. Hamer OW, Gnad M, Scholmerich J, Palitzsch KD. Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis. Eur J Gastroenterol Hepatol 2001;13:985-988. (Pubitemid 32757022)
72. Gravholt CH, Juul S, Naeraa RW, Hansen J. Prenatal and postnatal prevalence of Turner's syndrome: A registry study. BMJ 1996;312:16-21. (Pubitemid 26011883)
73. Hanson L, Bryman I, Barrenas ML, et al. Genetic analysis of mosaicism in 53 women with Turner syndrome. Hereditas 2001;134:153-159. (Pubitemid 33048751)
74. Bondy CA. Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10-25. (Pubitemid 46067503)
75. Balen AH, Harris SE, Chambers EL, Picton HM. Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome. Br J Obstet Gynaecol 2010; 117:238-242.
76. Kavoussi SK, Fisseha S, Smith YR, Smith GD, Christman GM, Gago LA. Oocyte cryopreservation in a woman with mosaic Turner syndrome: A case report. J Reprod Med 2008;53:223-226. (Pubitemid 351498136)
77. El-Shawarby SA, Sharif F, Conway G, Serhal P, Davies M. Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: Another fertility preservation option in a dedicated UK clinic. Br J Obstet Gynaecol 2010;117:234-237.
78. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner's syndrome and fertility: Current status and possible putative prospects. Hum Reprod Update 2001;7:603-610. (Pubitemid 33069619)
79. Practice Committee American Society of Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2005;83:1074-1075.
80. Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: A national survey. Fertil Steril 2003;80:498-501. (Pubitemid 37102856)
81. Lin AE, Lippe BM, Geffner ME, et al. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 1986;109:820-826. (Pubitemid 17180585)
82. Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril 2009;92:464-470.
83. Toniolo D, Rizzolio F. X chromosome and ovarian failure. Semin Reprod Med 2007;25:264-271. (Pubitemid 47047910)
84. Guerrero NV, Singh RH, Manatunga A, Berry GT, Steiner RD, Elsas LJ 2nd. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 2000;137:833-841.
85. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304: 994-998. (Pubitemid 11156606)
86. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J Inherit Metab Dis 1990;13:802-818.
87. Knauff EA, Richardus R, Eijkemans MJ, et al. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci 2007;14:780-785. (Pubitemid 351903563)
88. Gubbels CS, Kuppens SM, Bakker JA, et al. Pregnancy in classic galactosemia despite undetectable anti-mullerian hormone. Fertil Steril 2009;91:e1213-1296.
89. Hirschberg AL. Polycystic ovary syndrome, obesity and reproductive implications. Womens Health (Lond) 2009;5: 529-540.
90. Livshits A, Seidman DS. Fertility issues in women with diabetes. Womens Health (Lond) 2009;5:701-707.
91. Nader S. Reproductive endocrinology: Live birth prediction in polycystic ovary syndrome. Nat Rev Endocrinol 2010;6:64-66.
92. Shayya R, Chang RJ. Reproductive endocrinology of adolescent polycystic ovary syndrome. Br J Obstet Gynaecol 2010;117:150-155.
93. Tulandi T, Huang JY, Tan SL. Preservation of female fertility: An essential progress. Obstet Gynecol 2008;112:1160-1172.
94. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005;83:1622-1628.
95. Roberts JE, Oktay K. Fertility preservation: A comprehensive approach to the young woman with cancer. J Natl Cancer Inst Monogr 2005:57-59.
96. Lee DM, Yeoman RR, Battaglia DE, et al. Live birth after ovarian tissue transplant. Nature 2004;428:137-138. (Pubitemid 38374297)
97. Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840. (Pubitemid 38368830)
98. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318-321. (Pubitemid 41058339)
99. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: Successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 2007;12:1437-1442.
100. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med 2008;359:2617-2618.
101. Donnez J, Dolmans MM, Demylle D, et al. Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410. (Pubitemid 39370715)
102. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011;43:437-450.
103. West-Farrell ER, Xu M, Gomberg MA, Chow YH, Woodruff TK, Shea LD. The mouse follicle microenvironment regulates antrum formation and steroid production: Alterations in gene expression profiles. Biol Reprod 2009;80: 432-439.
104. West ER, Shea LD, Woodruff TK. Engineering the follicle microenvironment. Semin Reprod Med 2007;25:287-299. (Pubitemid 47047912)
105. Xu M, Banc A, Woodruff TK, Shea LD. Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles. Biotechnol Bioeng 2009;103:378-386.
106. Xu M, West E, Shea LD, Woodruff TK. Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod 2006; 75:916-923. (Pubitemid 44845598)
107. Xu M, Woodruff TK, Shea LD: Bioengineering and the ovarian follicle. Cancer Treat Res 2007;138:75-82.
108. Jin S, Lei L, Shea LD, Zelinski MB, Stouffer RL, Woodruff TK. Markers of growth and development in primate primordial follicles are preserved after slow cryopreservation. Fertil Steril 2010;93:2627-2632.
109. Xu M, Barrett SL, West-Farrell E, et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod 2009;24:2531-2540.
110. Xu M, West-Farrell ER, Stouffer RL, Shea LD, Woodruff TK, Zelinski MB. Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol Reprod 2009;81:587-594.
111. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 2000;9: 401-405. (Pubitemid 30487421)
112. Dooley MA, Nair R. Therapy Insight: Preserving fertility in cyclophosphamide-treated patients with rheumatic disease. Nat Clin Pract Rheumatol 2008;4:250-257. (Pubitemid 351638682)
113. Sinha R, Dionne JM. Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy? Arch Dis Child 2008;93:444-445. (Pubitemid 352025802)
114. Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 2005;52:2761-2767. (Pubitemid 41369104)
115. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007;12:1055-1066. (Pubitemid 350007017)
116. Gardino SL, Jeruss JS, Woodruff TK. Using decision trees to enhance interdisciplinary team work: The case of oncofertility. J Assist Reprod Genet 2010;27:227-231.
117. Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril 2005;83:897-901.
118. Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001;77:157-165. (Pubitemid 32205057)
119. Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am 2007;33:345-358. (Pubitemid 46710332)